Is There Value or Risk in New Guidance on Myeloma Treatment?

In his blog, IMF Chairman Dr. Brian Durie comments on the myeloma treatment guidance issued last week by the National Comprehensive Cancer Network (NCCN). The NCCN says its “evidence blocks” approach will provide a tool to educate providers and patients about “efficacy, safety, and affordability” of treatments. It is just one of several recent efforts to evaluate and recommend specific cancer treatment paths. Dr. Durie weighs in on the relative merits and drawbacks of these efforts.
Source: International Myeloma Foundation - Category: Hematology Source Type: news